Tag: Prescription Drugs
Adaptation to Pharmacotherapy Does Not Up Smoking Cessation in Black Adults
No significant difference in verified seven-day abstinence seen by treatment group among Black adults who smoke daily
FDA Approves Subcutaneous Vyvgart Hytrulo for Generalized Myasthenia Gravis
Trial shows similar reductions in anti-acetylcholine receptor antibody levels to the intravenous formulation
ADA: Once-Daily Orforglipron Linked to Significant Weight Reduction
Weight reduction of at least 10 percent occurred in 46 to 75 percent receiving orforglipron by week 36
ADA: Bempedoic Acid Cuts MACE in Statin-Intolerant Patients
Significant risk reduction in primary end point of composite of cardiovascular death nonfatal myocardial infarction, nonfatal stroke, coronary revascularization
Second-Line Switch to Dolutegravir Noninferior in HIV
Switch noninferior for patients without genotype information with viral suppression while receiving regimen containing ritonavir-boosted protease inhibitor
Continuous Meropenem No Benefit in Critically Ill Patients With Sepsis
No improvement seen in composite of all-cause mortality and emergence of pandrug- or extensively drug-resistant bacteria
Novo Nordisk Moves to Stop Businesses From Selling Compounded Versions of Wegovy, Ozempic
Company has moved to stop some medical spas, weight loss clinics, and compounding pharmacies from selling compounded versions of semaglutide
Acupuncture, Doxylamine-Pyridoxine Ease Nausea, Vomiting in Pregnancy
Combination seems more effective than either treatment alone
Tranexamic Acid Does Not Up Functional Outcome After Major Trauma
No improvement seen in favorable functional outcome at six months, but reduced risk of death at 28 days after injury
Early Intervention for Psoriasis With Guselkumab Tied to Complete Response
Systemic responses seen across patient groups, but more complete skin clearance seen with short disease duration
